| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_381e65f52c34e12b1d49c2de7f0c03f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bdcb61528ea07d28cb15ac866773d73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d6f4380f8fc2bdfe87664beea0bc3d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e06ef62890dcaccb9f323ff61e2201a1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate |
2012-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb68a5f3a3c1ce80188de3044d562665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_242cb8c7e9f9a0ddfc69eb26ed7684d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67998b358147ceadc7fa908c76bf46e0 |
| publicationDate |
2013-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8574581-B2 |
| titleOfInvention |
Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof |
| abstract |
Monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes or neuraminidase glycoprotein of N1 subtypes of avian influenza virus (AIV) are provided. The monoclonal antibodies and related binding proteins are useful for the detection of H5 and N1 subtypes of AIV, including H5N1 subtypes and provide means for the diagnosis, surveillance and treatment of dangerous viral infections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10392432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9969794-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10689436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513553-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096657-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11453714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11780907-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016100807-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11230593-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019147867-A1 |
| priorityDate |
2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |